Global Search

Search articles, concepts, and chapters

Shingleton Bradford J

ORCIDOpenAlex19 articles in GJC

19 articles in GJC

6.

Canaloplasty: Three-year results of circumferential viscodilation and tensioning of Schlemm canal using a microcatheter to treat open-angle glaucoma.

Lewis Richard A, von Wolff Kurt, Tetz Manfred, Koerber Norbert, Kearney John R, Shingleton Bradford J et al.

J Cataract Refract SurgApr 2011140 citationsClinical Trial

Canaloplasty significantly and safely lowered intraocular pressure and medication use for three years in open-angle glaucoma patients, offering a sustained treatment option.

7.

Pseudoexfoliation: High risk factors for zonule weakness and concurrent vitrectomy during phacoemulsification.

Shingleton Bradford J, Marvin Alicia C, Heier Jeffrey S, O'Donoghue Mark W, Laul Anupam, Wolff Brian et al.

J Cataract Refract SurgAug 201041 citationsRetrospective Study

This study found PXF eyes with preoperative zonular weakness signs or prior fellow-eye complications had significantly higher rates of vitrectomy during cataract surgery, yet achieved good visual and IOP outcomes.

8.

Pseudoexfoliation and the cataract surgeon: preoperative, intraoperative, and postoperative issues related to intraocular pressure, cataract, and intraocular lenses.

Shingleton Bradford J, Crandall Alan S, Ahmed Iqbal Ike K

J Cataract Refract SurgJun 2009124 citationsReview

This review highlights that pseudoexfoliation complicates cataract surgery due to small pupils, zonule laxity, and IOP changes, necessitating specialized preoperative, intraoperative, and postoperative management for better patient outcomes.

9.

Canaloplasty: circumferential viscodilation and tensioning of Schlemm canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: two-year interim clinical study results.

Lewis Richard A, von Wolff Kurt, Tetz Manfred, Koerber Norbert, Kearney John R, Shingleton Bradford J et al.

J Cataract Refract SurgMay 2009125 citationsClinical Trial

Canaloplasty for open-angle glaucoma safely and effectively reduced intraocular pressure and medication use over two years. This offers a valuable treatment option for OAG patients.

All 19 articles loaded